I havent lost the pounds I wish but, its helping on the weight loss journey
Retatrutide is dosed once weekly by subcutaneous injection, titrated in 4-week steps from a 2 mg start through 4, 8 and 12 mg, with 12 mg being the maximum dose tested in the 2023 NEJM Phase 2 trial (24.2% mean weight loss at 48 weeks) [5][2]
Robert Kushner: I don't think that will occur
Stigma Reduction: The authors believe that having access to care from a specialized team will lead to less stigma as a result of a DTC platform
Tirzepatide offers a promising approach to combatting obesity and promoting sustainable weight loss
Currently, there are approved medications, especially those that act as GLP-1 and/or GIP agonists, that achieve significant body weight reduction (more than 10%), compared to placebo